Tetrahedron p. 5119 - 5128 (1998)
Update date:2022-07-29
Topics:
Krzyzanowska, Bozenna K.
He, Kaizhang
Hasan, Ahmad
Shaw, Barbara Ramsay
A new class of nucleotides, with one of the two non-bridging oxygens at α-phosphorus replaced by a borane (BH3) group, has shown potential applications in DNA sequencing. We have developed a convenient method for the synthesis of the 2'-deoxy-5'-(α-P-borano)triphosphates of adenosine, guanosine, cytidine, thymidine and uridine (6a-e) that is time and cost effective compared to the previously reported method. The appropriate base/sugar protected nucleoside 1 is phosphitylated with 2-chloro-4H-1,3,2- benzodioxaphosphorin-4-one to give the corresponding cyclic intermediate, 2- (2'-deoxyribonucleosidyl-5'-O-)-4H-1,3,2-benzodioxaphosphorin-4-one (2). The in situ reaction of 2 with pyrophosphate leads to P2,P3-dioxo-P1-(2'- deoxyribonucleosidyl-5')cyclotriphosphite (3). Subsequent reaction of 3 with N,N-diisopropylethylamine-borane complex yields P1-borano-(2'- deoxyribonucleosidyl-5')cyclotriphosphate (4), which upon hydrolysis under mild conditions gives the base/sugar protected 2'-deoxyribonucleoside-5'- (α-P-borano)triphosphate (5). Treatment of 5 with ammonia:methanol (2:1 v/v) yields the diastereoisomeric mixture of 2'-deoxyribonucleoside-5'-(α-P- borano)triphosphate (6). Separation of the two diastereoisomers of 6 is performed by reverse phase HPLC.
View MoreChangzhou BaoKang Pharmaceutical & Chemical Co., Ltd
Contact:(86) 519-88782201 88784080 88785278
Address:Henglin town, changzhou,Jiangsu
Shenyang Mole pharmaceutical Technology Development Co.,Ltd
Contact:+86-24-31204918/13889278616
Address:No.44, wanliutang road, shenhe District of Shenyang
Zhejiang Genebest Pharmaceutical Co.,Ltd.
Contact:0086-571-63532866
Address:No.1 Jinboshi Rd Lishan Town Fuyang City Zhejiang Province China
Contact:021
Address:Pudong
Beijing Huikang Boyuan Chemical Tech Co.,LTD
Contact:+86-10-68862197
Address:No.7 Haiying Road,Science City,Fengtai District,Beijing,China
Doi:10.1039/j39680002621
(1968)Doi:10.1016/S0040-4020(98)00307-X
(1998)Doi:10.1080/00397919808006864
(1998)Doi:10.1246/cl.1998.397
(1998)Doi:10.1080/15421406.2018.1450931
(2017)Doi:10.1016/j.bmc.2006.03.020
(2006)